<DOC>
	<DOCNO>NCT01462747</DOCNO>
	<brief_summary>The aim study evaluate effect rectally administer activate carbon ( medical device KULIST ) chronic , uncomplicated , perianal fistula .</brief_summary>
	<brief_title>Efficacy Safety Study Medical Device ( KULIST ) Treat Perianal Fistulas</brief_title>
	<detailed_description>Patients chronic uncomplicated perianal fistula locate levator ani treat twice daily KULIST 8 week . The efficacy evaluate mean overall clinical evaluation fistula closure , well anal ultrasonography . Also change Patient Assessment Symptoms Impact Daily Function evaluate . Safety evaluate standard adverse event /adverse device effect report .</detailed_description>
	<mesh_term>Fistula</mesh_term>
	<mesh_term>Rectal Fistula</mesh_term>
	<criteria>1 . Patients perianal fistula diagnose clinical examination evaluate `` healed/open '' 2 . Fistula classify intersphincteric transsphincteric accord Parks´classification ( Parks 1976 ) 3 . Superficial fistula involve part external sphincter muscle 4 . Age : ≥18 year ≤ 75 year 5 . Informed consent and/or Letter Authority ( applicable ) obtain Exclusion Criteria 6 . Inflammatory Bowel Disease ( IBD ) 7 . Rectovaginal fistulas 8 . Rectourethral fistulas 9 . Rectovesical fistula 10 . Extrasphincteric suprasphincteric fistula accord Parks´classification 11 . Complicated fistula ( eg . horse shoe fistula ) evaluate investigator . 12 . Any surgical treatment perianal fistula 13 . Colorectal and/or anal malignancy 14 . Other malignancy require active treatment 15 . Subcutaneous fistula involve part external sphincter 16 . Other disease per investigator 's opinion contraindicate 17 . Subjects able complete study procedure per investigator 's opinion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2013</verification_date>
</DOC>